These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7860393

  • 1. Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results.
    Tejedor M, Valerdi JJ, López R, Domínguez MA, Arias F, Illarramendi JJ, Martínez E.
    Int J Radiat Oncol Biol Phys; 1995 Feb 15; 31(4):813-8. PubMed ID: 7860393
    [Abstract] [Full Text] [Related]

  • 2. Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.
    Mirimanoff RO, Moro D, Bolla M, Michel G, Brambilla C, Mermillod B, Miralbell R, Alberto P.
    Int J Radiat Oncol Biol Phys; 1998 Oct 01; 42(3):487-94. PubMed ID: 9806505
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.
    Furuse K, Kubota K, Kawahara M, Kodama N, Ogawara M, Akira M, Nakajima S, Takada M, Kusunoki Y, Negoro S.
    J Clin Oncol; 1995 Apr 01; 13(4):869-75. PubMed ID: 7707113
    [Abstract] [Full Text] [Related]

  • 4. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M.
    Int J Radiat Oncol Biol Phys; 1996 May 01; 35(2):343-50. PubMed ID: 8635942
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902.
    Kubota K, Tamura T, Fukuoka M, Furuse K, Ikegami H, Ariyoshi Y, Kurita Y, Saijo N.
    Ann Oncol; 2000 Apr 01; 11(4):445-50. PubMed ID: 10847464
    [Abstract] [Full Text] [Related]

  • 6. Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial.
    Van den Brande P, De Ruysscher D, Vansteenkiste J, Spaas P, Specenier P, Demedts M.
    Lung Cancer; 1998 Oct 01; 22(1):45-53. PubMed ID: 9869107
    [Abstract] [Full Text] [Related]

  • 7. [Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma].
    Bretel JJ, Arriagada R, Le Chevalier T, Baldeyrou P, Grunenwald D, Le Péchoux C, Pellae-Cosset B, Ruffié P.
    Cancer Radiother; 1997 Oct 01; 1(2):148-53. PubMed ID: 9273186
    [Abstract] [Full Text] [Related]

  • 8. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.
    Hazuka MB, Crowley JJ, Bunn PA, O'Rourke M, Braun TJ, Livingston RB.
    J Clin Oncol; 1994 Sep 01; 12(9):1814-20. PubMed ID: 8083705
    [Abstract] [Full Text] [Related]

  • 9. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.
    Lee SW, Choi EK, Lee JS, Lee SD, Suh C, Kim SW, Kim WS, Ahn SD, Yi BY, Kim JH, Noh YJ, Kim SS, Koh Y, Kim DS, Kim WD.
    Int J Radiat Oncol Biol Phys; 2003 Jul 15; 56(4):996-1004. PubMed ID: 12829135
    [Abstract] [Full Text] [Related]

  • 10. Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601).
    Tsuchiya S, Ohe Y, Sugiura T, Fuwa N, Kitamoto Y, Mori K, Kobayashi H, Nakata K, Sawa T, Hirai K, Etoh T, Saka H, Saito A, Fukuda H, Ishizuka N, Saijo N, Japan Clinical Oncology Group Study.
    Jpn J Clin Oncol; 2001 Oct 15; 31(10):488-94. PubMed ID: 11696618
    [Abstract] [Full Text] [Related]

  • 11. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
    Pujol JL, Lafontaine T, Quantin X, Reme-Saumon M, Cupissol D, Khial F, Michel FB.
    Chest; 1999 Jan 15; 115(1):144-50. PubMed ID: 9925076
    [Abstract] [Full Text] [Related]

  • 12. [Concurrent high-dose thoracic irradiation plus daily low-dose cisplatin and vindesine in locally advanced unresectable stage III non-small cell lung cancer].
    Nakano K, Kumagai K, Ishida H, Kohjima N, Hiramoto T, Hada Y.
    Gan To Kagaku Ryoho; 1996 Jan 15; 23(1):57-61. PubMed ID: 8546470
    [Abstract] [Full Text] [Related]

  • 13. Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
    Le Péchoux C, Arriagada R, Le Chevalier T, Bretel JJ, Cosset BP, Ruffié P, Baldeyrou P, Grunenwald D.
    Int J Radiat Oncol Biol Phys; 1996 Jun 01; 35(3):519-25. PubMed ID: 8655375
    [Abstract] [Full Text] [Related]

  • 14. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M, Provencio M, Utracka-Hutka B, Villa E, Codes M, Kuten A, Henke M, Lopez M, Bell D, Biti G, Merimsky O, Beorchia A, Riggi M, Caux NR, Pouget JC, Dubray B, David P.
    J Thorac Oncol; 2008 Sep 01; 3(9):994-1002. PubMed ID: 18758302
    [Abstract] [Full Text] [Related]

  • 15. A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
    Atagi S, Kawahara M, Hosoe S, Ogawara M, Kawaguchi T, Okishio K, Naka N, Sunami T, Mitsuoka S, Akira M.
    Lung Cancer; 2002 Apr 01; 36(1):105-11. PubMed ID: 11891041
    [Abstract] [Full Text] [Related]

  • 16. Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: results of a phase I-II study by the GOTHA group. Group d'Oncologie Thoracique des Régions Alpines.
    Alberto P, Mirimanoff RO, Mermillod B, Leyvraz S, Nagy-Mignotte H, Bolla M, Wellmann D, Moro D, Brambilla E.
    Eur J Cancer; 1995 Apr 01; 31A(3):342-8. PubMed ID: 7786599
    [Abstract] [Full Text] [Related]

  • 17. Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.
    Tan EH, Wee J, Ang PT, Fong KW, Leong SS, Khoo KS, Tan T, Lee KS, Eng P, Hsu A, Tan YK, Chua EJ, Ong YY.
    Acta Oncol; 1999 Apr 01; 38(8):1005-9. PubMed ID: 10665753
    [Abstract] [Full Text] [Related]

  • 18. Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma.
    Pignon T, Ruggieri S, Boutin C, Gouvernet J, Irisson M, Juin P, Astoul P.
    Cancer; 1999 May 15; 85(10):2144-50. PubMed ID: 10326692
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 May 15; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 20. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.
    Cancer; 1996 Oct 15; 78(8):1701-7. PubMed ID: 8859183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.